IBDEI0ND ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,10678,2)
 ;;=^5007043
 ;;^UTILITY(U,$J,358.3,10679,0)
 ;;=I05.9^^68^674^20
 ;;^UTILITY(U,$J,358.3,10679,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10679,1,3,0)
 ;;=3^Rheumatic Mitral Valve Disease,Unspec
 ;;^UTILITY(U,$J,358.3,10679,1,4,0)
 ;;=4^I05.9
 ;;^UTILITY(U,$J,358.3,10679,2)
 ;;=^5007044
 ;;^UTILITY(U,$J,358.3,10680,0)
 ;;=I07.1^^68^674^21
 ;;^UTILITY(U,$J,358.3,10680,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10680,1,3,0)
 ;;=3^Rheumatic Tricuspid Insufficiency
 ;;^UTILITY(U,$J,358.3,10680,1,4,0)
 ;;=4^I07.1
 ;;^UTILITY(U,$J,358.3,10680,2)
 ;;=^5007048
 ;;^UTILITY(U,$J,358.3,10681,0)
 ;;=I07.9^^68^674^22
 ;;^UTILITY(U,$J,358.3,10681,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10681,1,3,0)
 ;;=3^Rheumatic Tricuspid Valve Disease,Unspec
 ;;^UTILITY(U,$J,358.3,10681,1,4,0)
 ;;=4^I07.9
 ;;^UTILITY(U,$J,358.3,10681,2)
 ;;=^5007051
 ;;^UTILITY(U,$J,358.3,10682,0)
 ;;=I08.0^^68^674^16
 ;;^UTILITY(U,$J,358.3,10682,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10682,1,3,0)
 ;;=3^Rheumatic Disorders of Mitral & Aortic Valves
 ;;^UTILITY(U,$J,358.3,10682,1,4,0)
 ;;=4^I08.0
 ;;^UTILITY(U,$J,358.3,10682,2)
 ;;=^5007052
 ;;^UTILITY(U,$J,358.3,10683,0)
 ;;=I09.89^^68^674^17
 ;;^UTILITY(U,$J,358.3,10683,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10683,1,3,0)
 ;;=3^Rheumatic Heart Diseases NEC
 ;;^UTILITY(U,$J,358.3,10683,1,4,0)
 ;;=4^I09.89
 ;;^UTILITY(U,$J,358.3,10683,2)
 ;;=^5007060
 ;;^UTILITY(U,$J,358.3,10684,0)
 ;;=I47.1^^68^674^24
 ;;^UTILITY(U,$J,358.3,10684,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10684,1,3,0)
 ;;=3^Supraventricular Tachycardia
 ;;^UTILITY(U,$J,358.3,10684,1,4,0)
 ;;=4^I47.1
 ;;^UTILITY(U,$J,358.3,10684,2)
 ;;=^5007223
 ;;^UTILITY(U,$J,358.3,10685,0)
 ;;=I48.0^^68^674^15
 ;;^UTILITY(U,$J,358.3,10685,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10685,1,3,0)
 ;;=3^Paroxysmal Atrial Fibrillation
 ;;^UTILITY(U,$J,358.3,10685,1,4,0)
 ;;=4^I48.0
 ;;^UTILITY(U,$J,358.3,10685,2)
 ;;=^90473
 ;;^UTILITY(U,$J,358.3,10686,0)
 ;;=I49.5^^68^674^23
 ;;^UTILITY(U,$J,358.3,10686,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10686,1,3,0)
 ;;=3^Sick Sinus Syndrome
 ;;^UTILITY(U,$J,358.3,10686,1,4,0)
 ;;=4^I49.5
 ;;^UTILITY(U,$J,358.3,10686,2)
 ;;=^110404
 ;;^UTILITY(U,$J,358.3,10687,0)
 ;;=I49.8^^68^674^3
 ;;^UTILITY(U,$J,358.3,10687,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10687,1,3,0)
 ;;=3^Cardiac Arrhythmias
 ;;^UTILITY(U,$J,358.3,10687,1,4,0)
 ;;=4^I49.8
 ;;^UTILITY(U,$J,358.3,10687,2)
 ;;=^5007236
 ;;^UTILITY(U,$J,358.3,10688,0)
 ;;=I49.9^^68^674^2
 ;;^UTILITY(U,$J,358.3,10688,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10688,1,3,0)
 ;;=3^Cardiac Arrhythmia,Unspec
 ;;^UTILITY(U,$J,358.3,10688,1,4,0)
 ;;=4^I49.9
 ;;^UTILITY(U,$J,358.3,10688,2)
 ;;=^5007237
 ;;^UTILITY(U,$J,358.3,10689,0)
 ;;=R00.1^^68^674^1
 ;;^UTILITY(U,$J,358.3,10689,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10689,1,3,0)
 ;;=3^Bradycardia,Unspec
 ;;^UTILITY(U,$J,358.3,10689,1,4,0)
 ;;=4^R00.1
 ;;^UTILITY(U,$J,358.3,10689,2)
 ;;=^5019164
 ;;^UTILITY(U,$J,358.3,10690,0)
 ;;=I34.1^^68^674^14
 ;;^UTILITY(U,$J,358.3,10690,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10690,1,3,0)
 ;;=3^Nonrheumatic Mitral Valve Prolapse
 ;;^UTILITY(U,$J,358.3,10690,1,4,0)
 ;;=4^I34.1
 ;;^UTILITY(U,$J,358.3,10690,2)
 ;;=^5007170
 ;;^UTILITY(U,$J,358.3,10691,0)
 ;;=D68.4^^68^675^1
 ;;^UTILITY(U,$J,358.3,10691,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10691,1,3,0)
 ;;=3^Acquired Coagulation Factor Deficiency
 ;;^UTILITY(U,$J,358.3,10691,1,4,0)
 ;;=4^D68.4
 ;;^UTILITY(U,$J,358.3,10691,2)
 ;;=^2235
 ;;^UTILITY(U,$J,358.3,10692,0)
 ;;=D59.9^^68^675^2
